Literature DB >> 1704218

Demonstration of an active component of inter-alpha-trypsin inhibitor in the brains of Alzheimer type dementia.

E Yoshida1, M Yoshimura, Y Ito, H Mihara.   

Abstract

The putative precursor of A4 amyloid protein associated with Alzheimer's disease is known to have a domain with an amino acid sequence characteristic of a Kunitz-type serine protease inhibitor. Human serum inter-alpha-trypsin inhibitor (ITI) is the most similar inhibitor. We screened brain tissues with senile dementia of the Alzheimer type in an attempt to detect ITI immunoreactivity employing immunohistochemical methods. For this purpose, we used the antibody raised against acid-stable proteinase inhibitor (ASPI) which is an active component of ITI. ASPI immunoreactivity was found to be localized in diffuse type senile plaques, the perivascular area and subpial layer. Reactive astrocytes with intense ASPI immunoreactivity were present in the pyramidal layer of the parahippocampus, where loss of neurons was observed. These findings suggest that ITI may be related to the pathogenesis of Alzheimer type dementia.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1704218     DOI: 10.1016/0006-291x(91)91520-m

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  10 in total

Review 1.  The inter-alpha-inhibitor family: from structure to regulation.

Authors:  J P Salier; P Rouet; G Raguenez; M Daveau
Journal:  Biochem J       Date:  1996-04-01       Impact factor: 3.857

2.  Longitudinal effects of intravenous immunoglobulin on Alzheimer's cerebrospinal fluid proteome.

Authors:  Gilda Shayan; Basia Adamiak; Leila H Choe; Norman Relkin; Kelvin H Lee
Journal:  Electrophoresis       Date:  2014-07       Impact factor: 3.535

3.  Anti-inflammatory and chondroprotective effect of TSG-6 (tumor necrosis factor-alpha-stimulated gene-6) in murine models of experimental arthritis.

Authors:  T Bárdos; R V Kamath; K Mikecz; T T Glant
Journal:  Am J Pathol       Date:  2001-11       Impact factor: 4.307

4.  Self antigen prognostic for human immunodeficiency virus disease progression.

Authors:  C L Bristow; H Patel; R R Arnold
Journal:  Clin Diagn Lab Immunol       Date:  2001-09

5.  Expression and localization of Inter-alpha Inhibitors in rodent brain.

Authors:  X Chen; L Rivard; S Naqvi; S Nakada; J F Padbury; J Sanchez-Esteban; E G Stopa; Y-P Lim; B S Stonestreet
Journal:  Neuroscience       Date:  2016-03-08       Impact factor: 3.590

6.  Serine protease inhibitor antithrombin III and its messenger RNA in the pathogenesis of Alzheimer's disease.

Authors:  R N Kalaria; T Golde; S N Kroon; G Perry
Journal:  Am J Pathol       Date:  1993-09       Impact factor: 4.307

7.  Ontogeny of inter-alpha inhibitor proteins in ovine brain and somatic tissues.

Authors:  Mariya S Spasova; Grazyna B Sadowska; Steven W Threlkeld; Yow-Pin Lim; Barbara S Stonestreet
Journal:  Exp Biol Med (Maywood)       Date:  2014-06

8.  Immunohistochemical demonstration of bikunin, a light chain of inter-alpha-trypsin inhibitor, in human brain tumors.

Authors:  E Yoshida; M Maruyama; M Sugiki; H Mihara
Journal:  Inflammation       Date:  1994-12       Impact factor: 4.092

9.  Ontogeny of inter-alpha inhibitor protein (IAIP) expression in human brain.

Authors:  Boram Kim; Suzanne De La Monte; Virginia Hovanesian; Aparna Patra; Xiaodi Chen; Ray H Chen; Miles C Miller; Mehmet Halit Pinar; Yow-Pin Lim; Edward G Stopa; Barbara S Stonestreet
Journal:  J Neurosci Res       Date:  2019-12-04       Impact factor: 4.164

10.  Systematic review of human post-mortem immunohistochemical studies and bioinformatics analyses unveil the complexity of astrocyte reaction in Alzheimer's disease.

Authors:  Lucía Viejo; Ayush Noori; Emily Merrill; Sudeshna Das; Bradley T Hyman; Alberto Serrano-Pozo
Journal:  Neuropathol Appl Neurobiol       Date:  2021-08-17       Impact factor: 6.250

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.